U.S. flag

An official website of the United States government, Department of Justice.

NCJRS Virtual Library

The Virtual Library houses over 235,000 criminal justice resources, including all known OJP works.
Click here to search the NCJRS Virtual Library

Fatal Diabetic Ketoacidosis and Antipsychotic Medication

NCJ Number
246052
Journal
Journal of Forensic Sciences Volume: 58 Issue: 2 Dated: March 2013 Pages: 398-403
Author(s)
Susan F. Ely, M.D., M.P.H.T.M.; Amber R. Neitzel, B.S.; James R. Gill, M.D.
Date Published
March 2013
Length
6 pages
Annotation
Hyperglycemia and new onset diabetes have been described with certain antipsychotic medications and some of the initial presentations are fatal diabetic ketoacidosis (DKA).
Abstract
Hyperglycemia and new onset diabetes have been described with certain antipsychotic medications and some of the initial presentations are fatal diabetic ketoacidosis (DKA). The researchers reported 17 deaths due to DKA in psychiatric patients treated with second generation antipsychotic medications. Death certificates and toxicology data were searched for DKA and hyperglycemia. The researchers reviewed the medical examiner records which included the autopsy, toxicology, police, and medical examiner investigators' reports. The decedents ranged in age from 32 to 57 years (average 48 years). There were 15 men and two women. The immediate cause of death was DKA in all. The psychiatric disorders included: 10 schizophrenia, 3 bipolar/schizophrenia, 2 bipolar, and two major depression. The most frequent atypical antipsychotic medications found were quetiapine and olanzapine followed by risperidone. In 16 deaths, the researchers considered the medication as primary or contributory to the cause of death. Abstract published by arrangement with John Wiley & Sons.